[go: up one dir, main page]

IT1255895B - Composizioni farmaceutiche contenenti una calcitonina - Google Patents

Composizioni farmaceutiche contenenti una calcitonina

Info

Publication number
IT1255895B
IT1255895B ITMI922400A ITMI922400A IT1255895B IT 1255895 B IT1255895 B IT 1255895B IT MI922400 A ITMI922400 A IT MI922400A IT MI922400 A ITMI922400 A IT MI922400A IT 1255895 B IT1255895 B IT 1255895B
Authority
IT
Italy
Prior art keywords
calcitonin
pharmaceutical compositions
compositions containing
polyglycolate
glyceride
Prior art date
Application number
ITMI922400A
Other languages
English (en)
Inventor
Laura Chiodini
Teodoro Fonio
Original Assignee
Laura Chiodini
Teodoro Fonio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laura Chiodini, Teodoro Fonio filed Critical Laura Chiodini
Publication of ITMI922400A0 publication Critical patent/ITMI922400A0/it
Priority to ITMI922400A priority Critical patent/IT1255895B/it
Priority to DE69319440T priority patent/DE69319440T2/de
Priority to PCT/EP1993/002874 priority patent/WO1994008622A1/en
Priority to US08/416,874 priority patent/US5719122A/en
Priority to AU51779/93A priority patent/AU5177993A/en
Priority to JP6509649A priority patent/JPH08505364A/ja
Priority to ES93922958T priority patent/ES2120516T3/es
Priority to EP93922958A priority patent/EP0665755B1/en
Priority to ZA937697A priority patent/ZA937697B/xx
Priority to CN93118487A priority patent/CN1091314A/zh
Priority to MX9306499A priority patent/MX9306499A/es
Publication of ITMI922400A1 publication Critical patent/ITMI922400A1/it
Application granted granted Critical
Publication of IT1255895B publication Critical patent/IT1255895B/it
Priority to GR980401789T priority patent/GR3027611T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composizioni farmaceutiche comprendenti una calcitonina e un gliceride poliglicolisato.
ITMI922400A 1992-10-20 1992-10-20 Composizioni farmaceutiche contenenti una calcitonina IT1255895B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ITMI922400A IT1255895B (it) 1992-10-20 1992-10-20 Composizioni farmaceutiche contenenti una calcitonina
ES93922958T ES2120516T3 (es) 1992-10-20 1993-10-15 Preparacion de composiciones farmaceuticas que contienen una calcitonina.
PCT/EP1993/002874 WO1994008622A1 (en) 1992-10-20 1993-10-15 Pharmaceutical compositions containing a calcitonin
US08/416,874 US5719122A (en) 1992-10-20 1993-10-15 Pharmaceutical compositions containing a calcitonin
AU51779/93A AU5177993A (en) 1992-10-20 1993-10-15 Pharmaceutical compositions containing a calcitonin
JP6509649A JPH08505364A (ja) 1992-10-20 1993-10-15 カルシトニン含有医薬組成物
DE69319440T DE69319440T2 (de) 1992-10-20 1993-10-15 Herstellung von pharmazeutischen zusammensetzungen, die calcitonin enthalten
EP93922958A EP0665755B1 (en) 1992-10-20 1993-10-15 Preparation of pharmaceutical compositions containing a calcitonin
ZA937697A ZA937697B (en) 1992-10-20 1993-10-18 Pharmaceutical compositions containing a calcitonin
CN93118487A CN1091314A (zh) 1992-10-20 1993-10-18 含有降钙素的药物组合物
MX9306499A MX9306499A (es) 1992-10-20 1993-10-19 Composiciones farmaceuticas que contienen una anfetamina.
GR980401789T GR3027611T3 (en) 1992-10-20 1998-08-07 Pharmaceutical compositions containing a calcitonin.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI922400A IT1255895B (it) 1992-10-20 1992-10-20 Composizioni farmaceutiche contenenti una calcitonina

Publications (3)

Publication Number Publication Date
ITMI922400A0 ITMI922400A0 (it) 1992-10-20
ITMI922400A1 ITMI922400A1 (it) 1994-04-20
IT1255895B true IT1255895B (it) 1995-11-17

Family

ID=11364142

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI922400A IT1255895B (it) 1992-10-20 1992-10-20 Composizioni farmaceutiche contenenti una calcitonina

Country Status (12)

Country Link
US (1) US5719122A (it)
EP (1) EP0665755B1 (it)
JP (1) JPH08505364A (it)
CN (1) CN1091314A (it)
AU (1) AU5177993A (it)
DE (1) DE69319440T2 (it)
ES (1) ES2120516T3 (it)
GR (1) GR3027611T3 (it)
IT (1) IT1255895B (it)
MX (1) MX9306499A (it)
WO (1) WO1994008622A1 (it)
ZA (1) ZA937697B (it)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0726075A1 (en) * 1995-02-08 1996-08-14 Therapicon Srl Pharmaceutical non-inorganic saline solutions for endonasal administration
GB9516268D0 (en) 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
GB2318056B (en) * 1995-08-08 1999-05-26 Danbiosyst Uk Composition for enhanced uptake of polar drugs from the colon
IS4518A (is) * 1997-07-09 1999-01-10 Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group Nýtt lyfjaform fyrir bóluefni
FR2773489B1 (fr) * 1998-01-15 2001-03-23 Immunotech Sa Nouvelle composition destinee a la voie oromuqueuse notamment pernasale
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
CA2344306A1 (en) * 1998-09-21 2000-03-30 Amato Pharmaceutical Products, Ltd. Oral drug delivery system for enhancing the bioavailability of active form of glycyrrhizin
AU6015400A (en) * 1999-07-16 2001-02-05 Amato Pharmaceutical Products, Ltd. Glycyrrhizin preparations for transmucosal absorption
AU783952B2 (en) 2000-02-04 2006-01-05 Unigene Laboratories, Inc. Nasal calcitonin formulations
US6531112B2 (en) * 2000-05-15 2003-03-11 Delrx Pharmaceutical Corporation Formulations for administering calcitonin and processes for preparing the same
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US20040241310A1 (en) * 2001-08-16 2004-12-02 Sveibjorn Gizurarson Method of producing antibodies ex-vivo
US20050063940A1 (en) * 2002-02-25 2005-03-24 Sveinbjorn Gizurarson Bioadhesive agent
US6855332B2 (en) 2002-07-03 2005-02-15 Lyfjathroun Hf. Absorption promoting agent
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9265725B2 (en) * 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20080138296A1 (en) * 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US20070292359A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US8486376B2 (en) * 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7700076B2 (en) * 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US20070292461A1 (en) * 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
EP1556009B2 (en) * 2002-10-25 2021-07-21 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US8119109B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US7812120B2 (en) 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8157788B2 (en) * 2003-11-06 2012-04-17 Paolo L. Manfredi Multi-site drug delivery platform
US20050136112A1 (en) * 2003-12-19 2005-06-23 Pediamed Pharmaceuticals, Inc. Oral medicament delivery system
US20050222539A1 (en) * 2004-03-30 2005-10-06 Pediamed Pharmaceuticals, Inc. Automatic injection device
JP2006169213A (ja) * 2004-12-20 2006-06-29 Pola Chem Ind Inc ゲル状組成物
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
CN101563058A (zh) * 2006-09-08 2009-10-21 弗米克斯有限公司 有色的或可着色的能起泡的组合物和泡沫
US20080206155A1 (en) * 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
EP1986473B1 (en) * 2007-04-03 2017-01-25 Tsinghua University Organic electroluminescent device
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
EP2242476A2 (en) * 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
KR101755042B1 (ko) 2008-12-22 2017-07-06 알레간 인코포레이티드 비내 데스모프레신 투여를 위한 장치
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
PT3679941T (pt) 2009-06-18 2022-11-10 Serenity Pharmaceuticals Llc Administração segura de desmopressina
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
JP6487534B2 (ja) 2014-09-05 2019-03-20 シンビオミックス セラピューティクス、エルエルシー 細菌性膣炎の治療に使用するためのセクニダゾール
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US20190008784A1 (en) * 2017-07-07 2019-01-10 Symbiomix Therapeutics, Llc Novel secnidazole soft gelatin capsule formulations and uses thereof
CN116173187B (zh) * 2023-03-14 2024-05-10 哈尔滨医科大学 降钙素在制备防治支架内再狭窄药物中的应用、药物涂层支架及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1098444A (en) * 1975-05-26 1981-03-31 Leo Geller Peptide preparations with prolonged action
GB9120672D0 (en) * 1991-09-28 1991-11-06 Ciba Geigy Ag Pharmaceutical compositions
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems

Also Published As

Publication number Publication date
ITMI922400A0 (it) 1992-10-20
DE69319440D1 (de) 1998-08-06
GR3027611T3 (en) 1998-11-30
JPH08505364A (ja) 1996-06-11
EP0665755B1 (en) 1998-07-01
AU5177993A (en) 1994-05-09
WO1994008622A1 (en) 1994-04-28
CN1091314A (zh) 1994-08-31
ES2120516T3 (es) 1998-11-01
MX9306499A (es) 1994-06-30
EP0665755A1 (en) 1995-08-09
US5719122A (en) 1998-02-17
DE69319440T2 (de) 1998-11-19
ZA937697B (en) 1995-04-18
ITMI922400A1 (it) 1994-04-20

Similar Documents

Publication Publication Date Title
IT1255895B (it) Composizioni farmaceutiche contenenti una calcitonina
MX9203236A (es) Composicion farmaceutica que comprende una ciclosporina.
IL109503A0 (en) Hiv protease inhibitors and pharmaceutical compositions containing them
KR960702303A (ko) 항억제제 제형 (Antidepressant Dosage Form)
DE69420988D1 (de) Zahnärztliche Ausgabeeinrichtung
IT9083386A0 (it) Dispensatore di sostanze immagazzinate
IL96691A0 (en) Hiv protease inhibitors and pharmaceutical compositions containing them
IL99957A0 (en) Piperidinylcamphorsulfonyl oxytocin antagonists and pharmaceutical compositions containing them
DE59204271D1 (de) Parfümspender.
DE69233258D1 (de) Pulverspender
MX9201710A (es) Carbamatos de rapamicina y composicion farmaceutica que los contiene.
ITMI922230A0 (it) Composizioni cosmetiche contenenti una vitamina e polietossilata
MA22490A1 (fr) Composition insecticide et unite insecticide
IL109712A0 (en) Arylating agents and pharmaceutical compositions containing them
ITMI912703A0 (it) Composizioni farmaceutiche contenenti una calcitonina
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
IT8921722A0 (it) Composizioni farmaceutiche stabili a base di calcitonina.
ZA934424B (en) Pharmaceutical compositions containing amidines and novel amidines.
KR930006258U (ko) 방향제 용기
KR940007408U (ko) 메세지 전달 카드
KR930004256U (ko) 화장품의 발생가스가 배출 가능한 용기
SE9201369D0 (sv) Reklambudskap
IL138575A0 (en) Amidino protease inhibitors and pharmaceutical compositions containing the same
ITMI920364A0 (it) Composizioni farmaceutiche a base di calcitonine
KR940017150U (ko) 광고용 용기

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971031